30
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Oral pH triggered colon-specific ketoprofen loaded microspheres for the better management of early morning symptoms associated with rheumatoid arthritis. Part I: Optimization, in-vitro, and ex-vivo characterization

, &
Received 26 Sep 2023, Accepted 29 Mar 2024, Published online: 09 Apr 2024

References

  • Mladenovska, K.; Raicki, R. S.; Janevik, E. I.; Ristoski, T.; Pavlova, M. J.; Kavrakovski, Z.; Dodov, M. G.; Goracinova, K. Colon-Specific Delivery of 5-Aminosalicylic Acid from Chitosan-Ca-Alginate Microparticles. Int J. Pharm 2007, 342, 124–136. DOI: 10.1016/j.ijpharm.2007.05.028.
  • Krishnamachari, Y.; Madan, P.; Lin, S. Development of PH-and Time-Dependent Oral Microparticles to Optimize Budesonide Delivery to Ileum and Colon. Int J. Pharm 2007, 338, 238–247. DOI: 10.1016/j.ijpharm.2007.02.015.
  • Onishi, H.; Oosegi, T.; Machida, Y. Efficacy and Toxicity of Eudragit-Coated Chitosan–Succinyl-Prednisolone Conjugate Microspheres Using Rats with 2, 4, 6-Trinitrobenzenesulfonic Acid-Induced Colitis. Int. J. Pharm. 2008, 358, 296–302. DOI: 10.1016/j.ijpharm.2008.02.015.
  • Anande, N. M.; Jain, S. K.; Jain, N. K. Con-A Conjugated Mucoadhesive Microspheres for the Colonic Delivery of Diloxanide Furoate. Int. J. Pharm. 2008, 359, 182–189. DOI: 10.1016/j.ijpharm.2008.04.009.
  • Jain, S. K.; Jain, A.; Gupta, Y.; Ahirwar, M. Design and Development of Hydrogel Beads for Targeted Drug Delivery to the Colon. Aaps Pharmscitech 2007, 8, E56–E41. DOI: 10.1208/pt0803056.
  • Chaurasia, M.; Chourasia, M. K.; Jain, N. K.; Jain, A.; Soni, V.; Gupta, Y.; Jain, S. K.; Ref, M. P. H. Cross-Linked Guar Gum Microspheres: A Viable Approach for Improved Delivery of Anticancer Drugs for the Treatment of Colorectal Cancer. Aaps Pharmscitech 2006, 7, 74–E151. DOI: 10.1208/pt070374.
  • Lamprecht, A.; Yamamoto, H.; Takeuchi, H.; Kawashima, Y. Microsphere Design for the Colonic Delivery of 5-Fluorouracil. J Control Release 2003, 90, 313–322. DOI: 10.1016/s0168-3659(03)00195-0.
  • Rahman, Z.; Kohli, K.; Khar, R. K.; Ali, M.; Charoo, N. A.; Shamsher, A. A. A. Characterization of 5-Fluorouracil Microspheres for Colonic Delivery. Aaps Pharmscitech 2006, 7, E47–E121. DOI: 10.1208/pt070247.
  • Zhao, X.-L.; Li, K.-X.; Zhao, X.-F.; Pang, D.-H.; Chen, D.-W. Study on Colon-Specific 5-Fu PH-Enzyme Di-Dependent Chitosan Microspheres. Chem. Pharm. Bull. (Tokyo) 2008, 56, 963–968. DOI: 10.1248/cpb.56.963.
  • Jain, D.; Panda, A. K.; Majumdar, D. K. Eudragit S100 Entrapped Insulin Microspheres for Oral Delivery. Aaps Pharmscitech. 2005, 6, E100–E107. DOI: 10.1208/pt060116.
  • Lemmer, B. Chronopharmacokinetics: Implications for Drug Treatment. J. Pharm Pharmacol. 1999, 51, 887–890. DOI: 10.1211/0022357991773294.
  • Rubinstein, A. Approaches and Opportunities in Colon-Specific Drug Delivery. Crit. Rev. Ther. Drug Carr. Syst. 1995, 12, 101–149.
  • Kinget, R.; Kalala, W.; Vervoort, L.; den Mooter, G. Colonic Drug Targeting. J. Drug Target 1998, 6, 129–149. DOI: 10.3109/10611869808997888.
  • Kumar, S. P.; Prathibha, D.; Parthibarajan, R.; Reichal, C. R. Novel Colon Specific Drug Delivery System: A Review. Int. J. Pharm. Pharm. Sci. 2012, 4, 22–29.
  • Belali, N.; Wathoni, N.; Muchtaridi, M. Advances in Orally Targeted Drug Delivery to Colon. J. Adv. Pharm. Technol. Res. 2019, 10, 100–106. DOI: 10.4103/japtr.JAPTR_26_19.
  • Rahman, M. A.; Ahmed, N.; Hasan, I.; Reza, M. S. Formulation and in Vitro Assessment of Eudragit L 100 and Eudragit S 100 Based Naproxen Microspheres. Dhaka Univ. J. Pharm. Sci 2016, 15, 47–55. DOI: 10.3329/dujps.v15i1.29192.
  • Liu, L.; Yao, W.; Rao, Y.; Lu, X.; Gao, J. PH-Responsive Carriers for Oral Drug Delivery: Challenges and Opportunities of Current Platforms. Drug Deliv 2017, 24, 569–581. DOI: 10.1080/10717544.2017.1279238.
  • Jablan, J.; Jug, M. Development of Eudragit®s100 Based PH-Responsive Microspheres of Zaleplon by Spray-Drying: Tailoring the Drug Release Properties. Powder Technol 2015, 283, 334–343. DOI: 10.1016/j.powtec.2015.05.045.
  • Patel, M. M.; Amin, A. F. Design and Optimization of Colon-Targeted System of Theophylline for Chronotherapy of Nocturnal Asthma. J. Pharm Sci 2011, 100, 1760–1772. DOI: 10.1002/jps.22406.
  • Jain, V.; Jain, D.; Singh, R. Factors Effecting the Morphology of Eudragit S-100 Based Microsponges Bearing Dicyclomine for Colonic Delivery. J. Pharm Sci 2011, 100, 1545–1552. DOI: 10.1002/jps.22360.
  • Rizi, K.; Green, R. J.; Donaldson, M.; Williams, A. C. Production of PH-Responsive Microparticles by Spray Drying: Investigation of Experimental Parameter Effects on Morphological and Release Properties. J. Pharm Sci 2011, 100, 566–579. DOI: 10.1002/jps.22291.
  • Gavini, E.; Spada, G.; Rassu, G.; Cerri, G.; Brundu, A.; Cossu, M.; Sorrenti, M.; Giunchedi, P. Development of Solid Nanoparticles Based on Hydroxypropyl-$β$-Cyclodextrin Aimed for the Colonic Transmucosal Delivery of Diclofenac Sodium. J. Pharm Pharmacol 2011, 63, 472–482. DOI: 10.1111/j.2042-7158.2010.01220.x.
  • Marvola, M.; Nykänen, P.; Rautio, S.; Isonen, N.; Autere, A.-M. Enteric Polymers as Binders and Coating Materials in Multiple-Unit Site-Specific Drug Delivery Systems. Eur J. Pharm Sci 1999, 7, 259–267. DOI: 10.1016/s0928-0987(98)00032-3.
  • Jeong, Y.-I.; Ohno, T.; Hu, Z.; Yoshikawa, Y.; Shibata, N.; Nagata, S.; Takada, K. Evaluation of an Intestinal Pressure-Controlled Colon Delivery Capsules Prepared by a Dipping Method. J. Control Release 2001, 71, 175–182. DOI: 10.1016/s0168-3659(01)00211-5.
  • Ishibashi, T.; Hatano, H.; Kobayashi, M.; Mizobe, M.; Yoshino, H. Design and Evaluation of a New Capsule-Type Dosage Form for Colon-Targeted Delivery of Drugs. Int. J. Pharm. 1998, 168, 31–40. DOI: 10.1016/S0378-5173(98)00082-9.
  • Vilas, S.; Thilagar, S. Formulation and Optimisation of Lamivudine‐Loaded Eudragit® s 100 Polymer‐Coated Pectin Microspheres for Colon‐Specific Delivery. IET Nanobiotechnol. 2021, 15, 90–99. DOI: 10.1049/nbt2.12010.
  • Qazi, F.; Shoaib, M. H.; Yousuf, R. I.; Siddiqui, F.; Nasiri, M. I.; Ahmed, K.; Muhammad, IN.; Ahmed, F. R. QbD Based Eudragit Coated Meclizine HCl Immediate and Extended Release Multiparticulates: Formulation, Characterization and Pharmacokinetic Evaluation Using HPLC-Fluorescence Detection Method. Sci. Rep. 2020, 10, 14765. DOI: 10.1038/s41598-020-71751-y.
  • Lorenzo-Lamosa, M. L.; Remuñán-López, C.; Vila-Jato, J. L.; Alonso, M. J. Design of Microencapsulated Chitosan Microspheres for Colonic Drug Delivery. J Control Release 1998, 52, 109–118. DOI: 10.1016/s0168-3659(97)00203-4.
  • Villar-López, M. E.; Nieto-Reyes, L.; Anguiano-Igea, S.; Otero-Espinar, F. J.; Blanco-Méndez, J. Formulation of Triamcinolone Acetonide Pellets Suitable for Coating and Colon Targeting. Int. J. Pharm. 1999, 179, 229–235. DOI: 10.1016/s0378-5173(98)00369-x.
  • de Brito, M. J. L. G.; Ferreira, J.; Others, P. M. Microparticles for Delivering Therapeutic Peptides and Proteins to the Lumen of the Small Intestine. Eur J. Pharm. Biopharm. 2001, 52, 39–44. DOI: 10.1016/s0939-6411(01)00148-5.
  • Meyer, J. H.; Dressman, J.; Fink, A.; Amidon, G. Effect of Size and Density on Canine Gastric Emptying of Nondigestible Solids. Gastroenterology 1985, 89, 805–813. DOI: 10.1016/0016-5085(85)90576-1.
  • Davis, S. S. Assessment of Gastrointestinal Transit and Drug Absorption. Nov. Drug Deliv. its Ther. Appl. Wiley, Cichester 1989, 79, 89–101.
  • Myers, C.; Koki, A.; Pamukcu, R.; Wechter, W.; Padley, R. J. Proapoptotic anti-Inflammatory Drugs. Urology 2001, 57, 73–76. DOI: 10.1016/s0090-4295(00)00945-6.
  • Yamazaki, R.; Kusunoki, N.; Matsuzaki, T.; Hashimoto, S.; Kawai, S. Selective Cyclooxygenase-2 Inhibitors Show a Differential Ability to Inhibit Proliferation and Induce Apoptosis of Colon Adenocarcinoma Cells. FEBS Lett 2002, 531, 278–284. DOI: 10.1016/s0014-5793(02)03535-4.
  • Sanka, K.; Pragada, R. R.; Veerareddy, P. R. A PH-Triggered Delayed-Release Chronotherapeutic Drug Delivery System of Aceclofenac for Effective Management of Early Morning Symptoms of Rheumatoid Arthritis. J. Microencapsul. 2015, 32, 794–803. DOI: 10.3109/02652048.2015.1081417.
  • Buttgereit, F.; Doering, G.; Schaeffler, A.; Witte, S.; Sierakowski, S.; Gromnica-Ihle, E.; Jeka, S.; Krueger, K.; Szechinski, J.; Alten, R. Efficacy of Modified-Release versus Standard Prednisone to Reduce Duration of Morning Stiffness of the Joints in Rheumatoid Arthritis (CAPRA-1): A Double-Blind, Randomised Controlled Trial. Lancet 2008, 371, 205–214. DOI: 10.1016/S0140-6736(08)60132-4.
  • Jung, Y. J.; Lee, J. S.; Kim, Y. M. Colon-Specific Prodrugs of 5-Aminosalicylic Acid: Synthesis and in Vitro/in Vivo Properties of Acidic Amino Acid Derivatives of 5-Aminosalicylic Acid. J. Pharm Sci 2001, 90, 1767–1775. DOI: 10.1002/jps.1126.
  • Shruti Chopra, S. C.; Motwani, S. K.; Zeenat Iqbal, Z. I.; Sushma Talegaonkar, S. T.; Ahmad, F. J.; Khar, R. K. Optimisation of Polyherbal Gels for Vaginal Drug Delivery by Box-Behnken Statistical Design. Eur J. Pharm Biopharm 2007, 67, 120–131. DOI: 10.1016/j.ejpb.2006.12.013.
  • Chopra, S.; Patil, G. V.; Motwani, S. K. Release Modulating Hydrophilic Matrix Systems of Losartan Potassium: Optimization of Formulation Using Statistical Experimental Design. Eur J. Pharm Biopharm 2007, 66, 73–82. DOI: 10.1016/j.ejpb.2006.09.001.
  • Chaudhary, H.; Kohli, K.; Amin, S.; Rathee, P.; Kumar, V. Optimization and Formulation Design of Gels of Diclofenac and Curcumin for Transdermal Drug Delivery by Box-Behnken Statistical Design. J. Pharm Sci 2011, 100, 580–593. DOI: 10.1002/jps.22292.
  • Zhang, T.; Murowchick, J.; Bi-Botti, C. Y. Optimization of Formulation Variables Affecting Spray-Dried Oily Core Nanocapsules by Response Surface Methodology. J. Pharm Sci 2011, 100, 1031–1044. DOI: 10.1002/jps.22341.
  • Rapolu, K.; Sanka, K.; Vemula, P. K.; Aatipamula, V.; Mohd, A. B.; Diwan, P. V. Optimization and Characterization of Gastroretentive Floating Drug Delivery System Using Box-Behnken Design. Drug Dev. Ind. Pharm. 2013, 39, 1928–1935. DOI: 10.3109/03639045.2012.699068.
  • Yang, M.; Cui, F.; You, B.; Wang, L.; Yue, P.; Kawashima, Y. A Novel PH-Dependent Gradient-Release Delivery System for Nitrendipine: II. Investigations of the Factors Affecting the Release Behaviors of the System. Int J. Pharm 2004, 286, 99–109. DOI: 10.1016/j.ijpharm.2004.08.007.
  • Rajinikanth, P. S.; Karunagaran, L. N.; Balasubramaniam, J.; Mishra, B. Formulation and Evaluation of Clarithromycin Microspheres for Eradication of Helicobacter Pylori. Chem. Pharm. Bull (Tokyo) 2008, 56, 1658–1664. DOI: 10.1248/cpb.56.1658.
  • Xu, J.; Li, W.; Liu, Z.; Li, J.; Zhao, X.; Li, D. Y.; Guo, S.; Zhang, X.; Ref, D. S. C. Preparation, Characterization and Pharmacokinetics Evaluation of Clarithromycin-Loaded Eudragit®L-100 Microspheres. Eur. J. Drug Metab. Pharmacokinet 2016, 41, 287–293. DOI: 10.1007/s13318-015-0261-x.
  • Ahmadi, S.; Sheikh-Zeinoddin, M.; Soleimanian-Zad, S.; Alihosseini, F.; Yadav, H. Effects of Different Drying Methods on the Physicochemical Properties and Antioxidant Activities of Isolated Acorn Polysaccharides. Lebensm Wiss Technol 2019, 100, 1–9. DOI: 10.1016/j.lwt.2018.10.027.
  • Kumar, S. R.; Piyush, T.; Suman, R.; Akanksha, T. Preparation and Characterization of Cross-Linked Guar Gum Microspheres: Optimization Using Factorial Design. Chem. Pharm. Bull. (Tokyo) 2011, 59, 185–190. DOI: 10.1248/cpb.59.185.
  • Mongia, P.; Khatik, R.; Raj, R.; Jain, N.; Pathak, A. K. Ph-Sensitive Eudragit S-100 Coated Chitosan Nanoparticles of 5-Amino Salicylic Acid for Colon Delivery. J. Biomater. Tissue Eng. 2014, 4, 738–743. DOI: 10.1166/jbt.2014.1229.
  • Mazumder, R.; Mahanti, B.; Majumdar, S.; Pal, R.; Chowdhury, A. D. Response Surface Method for Optimization of Prepared Satranidazole Powder Layered Pellets. Futur. J. Pharm. Sci. 2021, 7, 190. DOI: 10.1186/s43094-021-00337-w.
  • Madaka, S.; Sanka, K.; Veerareddy, P. R. Design and Evaluation of Hydrochlorothiazide Gastroretentive Floating Drug Delivery System. Asian J. Pharm. Sci 2011, 6, 208–217.
  • Sanka, K.; Poienti, S.; Mohd, A. B.; Diwan, P. V. Improved Oral Delivery of Clonazepam through Liquisolid Powder Compact Formulations: In-Vitro and Ex-Vivo Characterization. Powder Technol. 2014, 256, 336–344. DOI: 10.1016/j.powtec.2014.02.026.
  • Dhadde, G. S.; Mali, H. S.; Raut, I. D.; Nitalikar, M. M.; Bhutkar, M. A. A Review on Microspheres: Types, Method of Preparation, Characterization and Application. AJPT 2021, 11, 149–155. DOI: 10.52711/2231-5713.2021.00025.
  • Lakshmi, P. U.; Tejaswini, K.; Hemalatha, B.; Padmalatha, K. Microspheres: A Comprehensive Review. Asian J. Res in Pharm Sci 2023, 13, 1–12.
  • Jabar, A.; Madni, A.; Bashir, S.; Tahir, N.; Usman, F.; Rahim, M. A.; Jan, N.; Shah, H.; Khan, A.; Khan, S. Statistically Optimized Pentazocine Loaded Microsphere for the Sustained Delivery Application: Formulation and Characterization. PLoS One 2021, 16, e0250876. DOI: 10.1371/journal.pone.0250876.
  • Alsayad, R.; Laham, A. Investigation of the Effects of Some Process Variables on the Azithromycin Microencapsulation by the Quasi-Emulsion Solvent Evaporation Method. RJPT 2023, 16, 3909–3914. DOI: 10.52711/0974-360X.2023.00643.
  • Okunlola, A.; Ghomorai, T. Development of Ibuprofen Microspheres Using Acetylated Plantain Starches as Polymer for Sustained Release. J. Pharm. Investig 2018, 48, 551–564. DOI: 10.1007/s40005-017-0345-5.
  • Zhao, J.; Wang, L.; Fan, C.; Yu, K.; Liu, X.; Zhao, X.; Wang, D.; Liu, W.; Su, Z.; Sun, F.; Li, Y. Development of near Zero-Order Release PLGA-Based Microspheres of a Novel Antipsychotic. Int J. Pharm 2017, 516, 32–38. DOI: 10.1016/j.ijpharm.2016.11.007.
  • Tandale, S. R.; Mole, M. M.; Gawade, V. R. Review on Novel Drug Delivery System of Microsphere: Type, Material, Method of Preparation and Evaluation. Publ. Int. J. Trend Sci. Res. Dev. (IJTSRD) 2020, 4, 2456–6470.
  • Verma, R.; Verma, S.; Kumar, S. Microsphere-a Novel Drug Delivery System. Res. Chron. Heal. Sci. 2019, 5, 5–14.
  • Paterakis, P. G.; Korakianiti, E. S.; Dallas, P. P.; Rekkas, D. M. Evaluation and Simultaneous Optimization of Some Pellets Characteristics Using a 33 Factorial Design and the Desirability Function. Int J. Pharm 2002, 248, 51–60. DOI: 10.1016/s0378-5173(02)00341-1.
  • Choi, S.-H.; Kim, S.-Y.; Ryoo, J. J.; Park, J. Y.; Lee, K.-P. FT-Raman and FT-IR Spectra of the Non-Steroidal anti-Inflammatory Drug Ketoprofen Included in Cyclodextrins. Anal. Sci. 2002, 17, i785–i788.
  • Al-Tahami, K. Preparation, Characterization, and in Vitro Release of Ketoprofen Loaded Alginate Microspheres. Int. J. Appl. Pharm. 2014, 6, 9–12.
  • Agarwal, S.; Thakur, A.; Sharma, A. Development and Evaluation of Ketoprofen Loaded Floating Microspheres for Sustained Delivery. Mater. Today Proc 2022, 68, 647–652. DOI: 10.1016/j.matpr.2022.05.299.
  • Mathew, S. T.; Gayathri Devi, S.; Prasanth, V. V.; Vinod, B. Formulation and in Vitro–in Vivo Evaluation of Ketoprofen-Loaded Albumin Microspheres for Intramuscular Administration. J. Microencapsul. 2009, 26, 456–469. DOI: 10.1080/02652040802420367.
  • de Alencar, R. G.; de Oliveira, A. C.; Lima, E. M.; da Cunha-Filho, M. S. S.; Taveira, S. F.; Marreto, R. N. Compacted Multiparticulate Systems for Colon-Specific Delivery of Ketoprofen. AAPS PharmSciTech 2017, 18, 2260–2268. DOI: 10.1208/s12249-016-0700-2.
  • Subhabrota, M.; Souvik, R.; Subhadeep, C. Preparation and Gamma Scintigraphic Evaluation of Colon Specific Pellets of Ketoprofen Prepared by Powder Layering Technology. Daru 2011, 19, 47–56.
  • Majumdar, S.; Lukka, V. K. Pectin Based Multiparticulate Formulation of Ketoprofen for Bacterial Enzyme Dependent Drug Release in Colon. Trends Biomater. Artif. Organs 2011, 25, 133–144.
  • Sanjeevani, D.; Kranti, T.; Ajinath, S.; Aparna, B.; Padm, S. S.; Patil, D. Y. Development of Colon Targeted Delivery of Ketoprofen Using Natural Gums as Carrier. Res. J. Pharm. Technol. 2009, 2, 771–776.
  • Maestrelli, F.; Zerrouk, N.; Cirri, M.; Mennini, N.; Mura, P. Microspheres for Colonic Delivery of Ketoprofen-Hydroxypropyl-$β$-Cyclodextrin Complex. Eur J. Pharm. Sci. 2008, 34, 1–11. DOI: 10.1016/j.ejps.2008.02.001.
  • Agarwal, D.; Ranawat, M. S.; Chauhan, C. S.; Kamble, R. Formulation and Charecterisation of Colon Targeted Ph Dependent Microspheres of Capecitabine for Colorectal Cancer. J. Drug Deliv. Ther. 2013, 3, 215–222.
  • Chourasia, M. K.; Jain, S. K. Design and Development of Multiparticulate System for Targeted Drug Delivery to Colon. Drug Deliv 2004, 11, 201–207. DOI: 10.1080/10717540490445955.
  • Kshirsagar, S. J.; Bhalekar, M. R.; Umap, R. R. In Vitro in Vivo Comparison of Two PH Sensitive Eudragit Polymers for Colon Specific Drug Delivery. J. Pharm. Sci. Res 2009, 1, 61.
  • Paharia, A.; Yadav, A. K.; Rai, G.; Jain, S. K.; Pancholi, S. S.; Agrawal, G. P. Eudragit-Coated Pectin Microspheres of 5-Fluorouracil for Colon Targeting. Aaps Pharmscitech 2007, 8, 12–E93. DOI: 10.1208/pt0801012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.